IL1B and asthma: p38 MAPK, IL-6, and IL-1β are all important targets of the inflammatory response in NA asthma and are involved in the mechanism of steroid resistance in NA therapy (Sánchez-Ovando et al., 2021; Chen et al., 2022; Xie et al., 2022).